ETPrime

Anuh Pharma Share Price

  • 167.885.76 (3.56%)
  • Volume: 10,830
  • Live
  • Last Updated On: 12 May, 2025, 12:13 PM IST
STOCK SCORE
ETPrime Only
  • 1D
  • 1W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Loading...
Anuh Pharma Share Price
  • 167.885.76 (3.56%)
  • Volume: 10,830
Advertisment

Anuh Pharma share price insights

View All

  • Company has spent less than 1% of its operating revenues towards interest expenses and 3.0% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

  • Stock gave a 3 year return of 79.3% as compared to Nifty Smallcap 100 which gave a return of 75.86%. (as of last trading session)

  • Stock generated 79.3% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

  • Anuh Pharma Ltd. share price moved up by 3.56% from its previous close of Rs 162.12. Anuh Pharma Ltd. stock last traded price is 167.88

    Share PriceValue
    Today/Current/Last167.88
    Previous Day162.12161.90

InsightsAnuh Pharma

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)    		16.77
    EPS - TTM
    (₹)    		10.03
    MCap
    (₹ Cr.)    		842.33
    Sectoral MCap Rank
    		79
    PB Ratio
    (x)    		2.79
    Div Yield
    (%)    		1.49
    Face Value
    (₹)    		5.00
    Beta

    Beta

    1 Month-
    3 Months-
    6 Months-
    1 Year-
    3 Years-

    		-
    VWAP
    (₹)    		168.24
    52W H/L
    (₹)
    245.70 / 148.50

    Anuh Pharma Share Price Returns

    1 Day3.56%
    1 Week-1.24%
    1 Month-2.39%
    3 Months-3.16%
    1 YearN.A.
    3 YearsN.A.
    5 YearsN.A.

    ET Stock ScreenersTop Score Companies

    Check whether Anuh Pharma belongs to analysts' top-rated companies list?

    View Stock Screeners

    Anuh Pharma News & Analysis

    View all Anuh Pharma Share News & Announcements

    Anuh Pharma Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Anuh Pharma Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Anuh Pharma Financials

    • Insights

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 3.0% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)
      Quarterly | AnnualDec 2024Sep 2024Jun 2024Mar 2024Dec 2023
      Total Income160.45169.35141.63166.71175.76
      Total Income Growth (%)-5.2619.58-15.05-5.1515.87
      Total Expenses146.91151.00129.22146.89150.31
      Total Expenses Growth (%)-2.7116.85-12.03-2.2712.41
      EBIT13.5518.3612.4119.8225.45
      EBIT Growth (%)-26.2147.95-37.39-22.1241.67
      Profit after Tax (PAT)10.3415.049.5115.3619.11
      PAT Growth (%)-31.2458.19-38.08-19.6538.16
      EBIT Margin (%)8.4410.848.7611.8914.48
      Net Profit Margin (%)6.458.886.719.2110.87
      Basic EPS (₹)2.063.001.903.063.81
      Quarterly | Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Revenue659.10533.60491.84442.50311.17
      Total Revenue Growth (%)23.528.4911.1542.20-4.36
      Total Expenses580.79486.13452.72403.95292.02
      Total Expenses Growth (%)19.477.3812.0738.33-0.32
      Profit after Tax (PAT)60.0636.1830.5628.4414.31
      PAT Growth (%)66.0018.387.4798.78-38.78
      Operating Profit Margin (%)12.159.048.239.276.49
      Net Profit Margin (%)9.286.856.276.584.66
      Basic EPS (₹)11.987.226.105.675.71

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Profit & Loss Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Total Assets445.68404.98347.17332.64326.37
      Total Assets Growth (%)10.0516.654.371.9235.83
      Total Liabilities154.46163.76133.40142.00164.17
      Total Liabilities Growth (%)-5.6822.76-6.06-13.50116.96
      Total Equity291.22241.22213.77190.64162.21
      Total Equity Growth (%)20.7312.8412.1317.53-1.45
      Current Ratio (x)2.201.911.981.701.37
      Total Debt to Equity (x)0.010.000.010.070.27
      Contingent Liabilities20.2930.3332.9223.3933.07

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Balance Sheet are available.

    • Insights

      • Cash from Operations vs PAT

        Operating cash flow of Rs 12.93 cr is 0.22 times compared to the reported net profit of Rs 60.06 cr. (Source: Standalone Financials)
      Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Net Cash flow from Operating Activities12.9353.9028.86-18.7348.93
      Net Cash used in Investing Activities0.92-43.48-7.8252.20-76.53
      Net Cash flow from Financing Activities-8.57-12.29-19.45-33.1222.17
      Net Cash Flow5.27-1.871.600.35-5.43
      Closing Cash & Cash Equivalent7.201.933.802.201.85
      Closing Cash & Cash Equivalent Growth (%)273.76-49.2472.6619.14-74.63
      Total Debt/ CFO (x)0.160.000.11-0.730.91

      All figures in Rs Cr, unless mentioned otherwise

      View Details

      No reported Cash Flow Statement are available.

    • Annual FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
      Return on Equity (%)20.6214.9914.2914.918.81
      Return on Capital Employed (%)26.8419.5718.5320.7312.18
      Return on Assets (%)13.478.938.808.544.38
      Interest Coverage Ratio (x)246.74262.7754.1636.8825.18
      Asset Turnover Ratio (x)1.521.401.431.3194.05
      Price to Earnings (x)20.5311.0414.1015.9220.45
      Price to Book (x)4.231.652.012.371.80
      EV/EBITDA (x)14.026.848.038.0912.38
      EBITDA Margin (%)13.4810.8710.6912.768.78

      No reported Financial Ratios are available.

    Financial InsightsAnuh Pharma

    • Income (P&L)
    • Cash Flow

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 3.0% towards employee cost in the year ending Mar 31, 2024. (Source: Standalone Financials)

      • Cash from Operations vs PAT

        Operating cash flow of Rs 12.93 cr is 0.22 times compared to the reported net profit of Rs 60.06 cr. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Anuh Pharma Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Anuh Pharma Peer Comparison

      • CHART
      • TABLE

      Insights

      • Stock Returns vs Nifty Smallcap 100

        Stock gave a 3 year return of 79.3% as compared to Nifty Smallcap 100 which gave a return of 75.86%. (as of last trading session)

      • Stock Returns vs Nifty Pharma

        Stock generated 79.3% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

      • Choose from Peers

          Choose from Stocks

          • 1D
          • 1W
          • 1M
          • 3M
          • 6M
          • 1Y
          • 5Y
          Loading...

        • Insights

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 79.3% as compared to Nifty Smallcap 100 which gave a return of 75.86%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 79.3% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

          Ratio Performance

          NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
          Anuh Pharma16.772.8920.6226.8413.4714.0512.159.2811.982.200.010.16
          Lincoln Pharma12.721.9215.7320.3413.3212.5521.3016.0746.584.840.000.02
          Kopran Ltd18.921.8310.3714.516.857.1912.388.2910.572.080.202.29
          Wanbury Ltd19.2330.20200.2646.3416.2913.4310.419.7217.100.743.9427.64
          NGL Fine Chem21.392.6615.7320.7311.629.7716.4612.1966.882.460.121.59
          Add More
          Annual Ratios (%)

          Choose from Peers

          • Medicamen Bio
          • Nectar Lifesc
          • Albert David
          • Ind-Swift Labs
          • Medico Remedies

          Choose from Stocks

            See All Parameters

          Peers InsightsAnuh Pharma

          • Stock Returns vs Nifty Smallcap 100

            Stock gave a 3 year return of 79.3% as compared to Nifty Smallcap 100 which gave a return of 75.86%. (as of last trading session)

          • Stock Returns vs Nifty Pharma

            Stock generated 79.3% return as compared to Nifty Pharma which gave investors 67.29% return over 3 year time period. (as of last trading session)

          Do you find these insights useful?

          • hate it

          • meh

          • love it

          Anuh Pharma Shareholding Pattern

          • Loading...
            Showing Anuh Pharma Shareholding as on Mar 2025
            CategoryMar 2025Dec 2024Sep 2024Jun 2024
            Promoters69.9269.9269.9269.80
            Pledge0.000.000.000.00
            FII0.040.020.020.03
            DII0.000.000.000.00
            Mutual Funds0.000.000.000.00
            Others30.0330.0630.0630.17
          • Showing Shareholding as on Mar 2025
            CategoryNo. of SharesPercentage% Change QoQ
            Promoters3,50,36,45869.92 %0.00
            Pledge00.00 %0.00
            FII18,0590.04 %0.02
            DII52,5500.10 %0.10
            MF1380.00 %-
            Others1,50,04,93330.03 %-0.02

          Anuh Pharma MF Ownership

          MF Ownership details are not available.

          Top Searches:
          Anuh Pharma News Anuh Pharma Quarterly Results Anuh Pharma Dividend Anuh Pharma Q1 ResultsAnuh Pharma Q2 ResultsAnuh Pharma Q3 ResultsAnuh Pharma Q4 Results

          Anuh Pharma Corporate Actions

          • Meeting DateAnnounced onPurposeDetails
            Feb 07, 2025Feb 01, 2025Board MeetingQuarterly Results & Others
            Nov 08, 2024Oct 29, 2024Board MeetingQuarterly Results
            Aug 23, 2024May 17, 2024AGMBook closure from Aug 17, 2024 to Aug 23, 2024
            Aug 09, 2024Aug 02, 2024Board MeetingQuarterly Results
            May 17, 2024May 09, 2024Board MeetingAudited Results & Final Dividend
          • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
            Final50%2.5Aug 16, 2024May 17, 2024
            Final40%2.0Aug 11, 2023May 19, 2023
            Final35%1.75Aug 03, 2022May 16, 2022
            Final30%1.5Aug 17, 2021May 21, 2021
            Interim55%2.75Mar 05, 2020Feb 24, 2020
          • All TypesEx-DateRecord DateAnnounced onDetails
            BonusSep 18, 2020Sep 21, 2020Aug 07, 2020Bonus Ratio: 1 share(s) for every 1 shares held
            BonusAug 05, 2015Aug 06, 2015Jun 12, 2015Bonus Ratio: 2 share(s) for every 1 shares held
            BonusOct 28, 2010Oct 29, 2010Aug 06, 2010Bonus Ratio: 2 share(s) for every 1 shares held
            SplitsJul 31, 2006Aug 07, 2006Apr 29, 2006Split: Old FV10.0| New FV:5.0
            BonusJul 31, 2006Aug 07, 2006Apr 29, 2006Bonus Ratio: 1 share(s) for every 1 shares held

          About Anuh Pharma

          Anuh Pharma Ltd., incorporated in the year 1960, is a Small Cap company (having a market cap of Rs 812.42 Crore) operating in Pharmaceuticals sector. Anuh Pharma Ltd. key Products/Revenue Segments include Bulk Drugs & Chemicals and Other Operating Revenue for the year ending 31-Mar-2023. Show More

          • Executives

          • Auditors

          • AT

            Arun Todarwal

            Chairman & Non-Exe.Director
            BN

            Bipin N Shah

            Vice Chairman
            RB

            Ritesh B Shah

            Joint Managing Director
            VB

            Vivek B Shah

            Joint Managing Director
            Show More
          • Jayantilal Thakkar & Co.

          Industry

          Pharma - Indian

          Key Indices Listed on

          -

          Address

          3-A, Shivsagar Estate,North Wing,Mumbai, Maharashtra - 400018

          Contact

          [email protected]

          http://www.anuhpharma.com

          More Details

          FAQs about Anuh Pharma share

          • 1. What is Anuh Pharma share price and what are the returns for Anuh Pharma share?
            Anuh Pharma share price is Rs 167.88 as on 12 May, 2025, 12:13 PM IST. Anuh Pharma share price is up by 3.56% based on previous share price of Rs. 164.5. In last 1 Month, Anuh Pharma share price moved down by 2.39%.
          • 2. What are the Anuh Pharma quarterly results?
            On Standalone basis, Anuh Pharma reported a total income and loss of Rs 160.45 Cr and Rs 10.34 respectively for quarter ending resultQuarterlyResult.list[0].yearEnding. Total Income and profit for the year ending 2024-03-31 was Rs 659.10 Cr and Rs 60.06 Cr.
          • 3. Which are the key peers to Anuh Pharma?
            Top 10 Peers for Anuh Pharma are Kopran Ltd., Nectar Lifesciences Ltd., NGL Fine - Chem Ltd., Wanbury Ltd., Albert David Ltd., Medicamen Biotech Ltd., Medico Remedies Ltd., Ind-Swift Laboratories Ltd., Lincoln Pharmaceuticals Ltd. and Zim Laboratories Ltd.
          • 4. What's the market capitalization of Anuh Pharma?
            Within the Pharmaceuticals sector, Anuh Pharma stock has a market cap rank of 79. Anuh Pharma has a market cap of Rs 842.33 Cr.
          • 5. What is the CAGR of Anuh Pharma?
            The CAGR of Anuh Pharma is 10.63.
          • 6. Who's the chairman of Anuh Pharma?
            Arun Todarwal is the Chairman & Non-Exe.Director of Anuh Pharma
          • 7. What is the PE & PB ratio of Anuh Pharma?
            The PE ratio of Anuh Pharma stands at 16.17, while the PB ratio is 2.79.
          • 8. Is Anuh Pharma giving dividend?
            Anuh Pharma Ltd. announced an equity dividend of 50% on a face value of 5.0 amounting to Rs 2.5 per share on 17 May 2024. The ex dividend date was 16 Aug 2024.
          • 9. Who owns Anuh Pharma?
            Promoter, DII and FII owns 69.92, 0.0 and 0.02 shares of Anuh Pharma as on 31 Mar 2025
            • There is no change in promoter holding from 31 Dec 2024 to 31 Mar 2025
            • Domestic Institutional Investors holding has gone up from 0.0 (30 Jun 2023) to 0.1 (31 Mar 2024)
            • Foreign Institutional Investors holding has gone up from 0.02 (31 Dec 2024) to 0.04 (31 Mar 2025)
            • Other investor holding have gone down from 30.06 (31 Dec 2024) to 30.03 (31 Mar 2025)
          • 10. What are the returns for Anuh Pharma share?
            Return Performance of Anuh Pharma Shares:
            • 1 Week: Anuh Pharma share price moved down by 1.24%
            • 1 Month: Anuh Pharma share price moved down by 2.39%
          • 11. What is 52 week high/low of Anuh Pharma share price?
            In last 52 weeks Anuh Pharma share had a high price of Rs 245.70 and low price of Rs 148.50
          • 12. How can I quickly analyze Anuh Pharma stock?
            Key Metrics for Anuh Pharma are:
            • PE Ratio of Anuh Pharma is 16.77
            • Price/Sales ratio of Anuh Pharma is 1.90
            • Price to Book ratio of Anuh Pharma is 2.79

          Trending in Markets

          Top Gainers As on 12:07 PM | 12 May 2025

          Reliance Power43.48
          4.83 (12.50%)
          Cera Sanitary6,533.00
          701.00 (12.02%)
          Syrma SGS Technology534.00
          55.56 (11.62%)
          Netweb Technologies1,741.10
          166.00 (10.54%)
          Nippon Life AMC686.60
          62.40 (10.00%)

          Top Losers As on 12:12 PM | 12 May 2025

          KPR Mill1,199.40
          -106.85 (-8.18%)
          IndusInd Bank793.30
          -24.91 (-3.05%)
          Sun Pharma1,693.10
          -51.71 (-2.97%)
          Concord Biotech Ltd.1,504.90
          -38.70 (-2.51%)
          Eris Lifesciences1,427.20
          -28.80 (-1.98%)

          DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

          DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

          By using this site, you agree to the Terms of Service and Privacy Policy.

          Business News›Markets›Stocks›Stock Price Quotes›Anuh Pharma Share Price
          The Economic Times
          BrowseCompanies:
          OSZAR »